Close

BIO Proposes Greater Public Access to Information on New Agricultural Biotechnology Products

The Biotechnology Innovation Organization (BIO) today put forward a consumer-friendly proposal that would improve public access to information about new agricultural biotechnology products. Combined with a new science-based regulatory approach, BIO’s proposal will foster greater public confidence and support bringing new sustainable agricultural solutions to the market.

BIO President: Executive Order on Agricultural Biotechnology Is ‘Important Step Forward’

The Biotechnology Innovation Organization (BIO) today expressed support for President Donald J. Trump’s executive order, titled “Modernizing the Regulatory Framework for Agricultural Biotechnology Products.” 

BIO Statement on USDA Proposed Rule for Biotechnology Regulations

The Biotechnology Innovation Organization (BIO) released the following statement on the U.S. Department of Agriculture’s (USDA) announcement of proposed revisions to its biotechnology regulations, referred to by the agency as the “SECURE” rule.

BIO Statement on Ambassador Lighthizer and Secretary Perdue Testimonies

BIO President and CEO Jim Greenwood released the following statement on U.S. Trade Representative Robert Lighthizer’s testimony at a House Ways and Means Committee hearing on the U.S.-China trade deal and U.S. Secretary of Agriculture Sonny Perdue’s testimony at a House Agriculture Committee hearing on the state of the rural economy.  

BIO Statement on China Approvals of Agricultural Biotechnology Products

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement on the announcement that the People’s Republic of China’s National Biosafety Committee approved the final safety certificate for five agricultural biotechnology products.

BIO/Food Value Chain letter to Senate and House Appropriations Committee leadership in support of legislative language ensuring consistency under the National Bioengineered Food Disclosure Law

September 21, 2018

...

BIO/Coalition for Safe, Affordable Food letter for Senate and House Ag Committee leadership in support of biotech education provision

Dear Chairman Roberts, Chairman Conaway, Ranking Member Stabenow, and Ranking Member Peterson: As representatives of the U.S. food and agricultural value chain and members of the Coalition for Safe, Affordable Food (the Coalition), we write to express our support for Section 7608 in the House-passed H.R. 2, the Agriculture Improvement Act of 2018, regarding public education on agricultural biotechnology. We believe these provisions will support the U.S. Department of Agriculture (USDA) and other relevant federal agencies in providing consumers with education materials on the National Bioengineered Food Disclosure Law (NBFDL) and its implementing regulations – the National Bioengineered Food Disclosure Standard (NBFDS). Such education materials can assist in explaining how the NBFDS provides consumers with information on the ingredients of the foods they eat, one overriding purpose of the NBFDL...

BIO Statement on Growing American Food Exports Act of 2018

The Biotechnology Innovation Organization (BIO) today released the following statement in response to the introduction of the bipartisan “Growing American Food Exports Act of 2018” (S. 3103) by Senator Todd Young (R-IN), Senator Joe Donnelly (D-IN), Senator Roy Blunt (R-MO), and Senator Claire McCaskill (D-MO):

BIO Food and Agriculture Section Comments to FDA on Guidance on Consultation Procedures: Foods Derived from New Plant Varieties

February 9, 2017 The Biotechnology Innovation Organization (BIO) is pleased to submit these comments in response to the U.S. Food and Drug Administration’s (FDA) request for public input on a notice published in the Federal Register1 regarding information collection burdens associated with its “Guidance on Consultation Procedures: Foods Derived from New Plant Varieties.”

BIO Food and Agriculture Section Comments to FDA on Review of Existing General Regulatory and Information Collection Requirements

February 5, 2017 The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to submit these comments in response to the U.S. Food and Drug Administration’s (FDA) request for public input on a notice published in the Federal Register entitled “Review of Existing General Regulatory and Information Collection Requirements of the Food and Drug Administration,” as well as several related Center-specific notices.